• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素受体在慢性丙型肝炎和肝细胞癌发病机制中的表达。

Estrogen receptor expression in chronic hepatitis C and hepatocellular carcinoma pathogenesis.

机构信息

Department of Biochemistry and Microbiology, Oklahoma State University-Center for Health Sciences, Tulsa, OK 74107, United States.

Immatics US Inc, Houston, TX 77077, United States.

出版信息

World J Gastroenterol. 2017 Oct 7;23(37):6802-6816. doi: 10.3748/wjg.v23.i37.6802.

DOI:10.3748/wjg.v23.i37.6802
PMID:29085224
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5645614/
Abstract

AIM

To investigate gender-specific liver estrogen receptor (ER) expression in normal subjects and patients with hepatitis C virus (HCV)-related cirrhosis and hepatocellular carcinoma (HCC).

METHODS

Liver tissues from normal donors and patients diagnosed with HCV-related cirrhosis and HCV-related HCC were obtained from the NIH Liver Tissue and Cell Distribution System. The expression of ER subtypes, ERα and ERβ, were evaluated by Western blotting and real-time RT-PCR. The subcellular distribution of ERα and ERβ was further determined in nuclear and cytoplasmic tissue lysates along with the expression of inflammatory [activated NF-κB and IκB-kinase (IKK)] and oncogenic (cyclin D1) markers by Western blotting and immunohistochemistry. The expression of ERα and ERβ was correlated with the expression of activated NF-κB, activated IKK and cyclin D1 by Spearman's correlation.

RESULTS

Both ER subtypes were expressed in normal livers but male livers showed significantly higher expression of ERα than females ( < 0.05). We observed significantly higher mRNA expression of ERα in HCV-related HCC liver tissues as compared to normals ( < 0.05) and ERβ in livers of HCV-related cirrhosis and HCV-related HCC subjects ( < 0.05). At the protein level, there was a significantly higher expression of nuclear ERα in livers of HCV-related HCC patients and nuclear ERβ in HCV-related cirrhosis patients as compared to normals ( < 0.05). Furthermore, we observed a significantly higher expression of phosphorylated NF-κB and cyclin D1 in diseased livers ( < 0.05). There was a positive correlation between the expression of nuclear ER subtypes and nuclear cyclin D1 and a negative correlation between cytoplasmic ER subtypes and cytoplasmic phosphorylated IKK in HCV-related HCC livers. These findings suggest that dysregulated expression of ER subtypes following chronic HCV-infection may contribute to the progression of HCV-related cirrhosis to HCV-related HCC.

CONCLUSION

Gender differences were observed in ERα expression in normal livers. Alterations in ER subtype expression observed in diseased livers may influence gender-related disparity in HCV-related pathogenesis.

摘要

目的

研究正常人和丙型肝炎病毒(HCV)相关肝硬化和肝细胞癌(HCC)患者肝雌激素受体(ER)的性别特异性表达。

方法

从 NIH 肝脏组织和细胞分配系统获得正常供体和诊断为 HCV 相关肝硬化和 HCV 相关 HCC 的患者的肝组织。通过 Western 印迹和实时 RT-PCR 评估 ER 亚型 ERα和 ERβ的表达。通过 Western 印迹和免疫组织化学进一步确定 ERα和 ERβ在核和细胞质组织裂解物中的亚细胞分布,以及炎症(激活的 NF-κB 和 IκB 激酶(IKK))和致癌(细胞周期蛋白 D1)标志物的表达。通过 Spearman 相关性分析将 ERα和 ERβ的表达与激活的 NF-κB、激活的 IKK 和细胞周期蛋白 D1 的表达相关联。

结果

两种 ER 亚型在正常肝脏中均有表达,但男性肝脏中 ERα的表达明显高于女性(<0.05)。与正常肝脏相比,我们观察到 HCV 相关 HCC 肝脏组织中 ERα 的 mRNA 表达明显升高(<0.05),而 HCV 相关肝硬化和 HCC 患者的 ERβ表达升高(<0.05)。在蛋白质水平上,与正常肝脏相比,HCV 相关 HCC 患者的核 ERα和 HCV 相关肝硬化患者的核 ERβ表达明显升高(<0.05)。此外,我们观察到病变肝脏中磷酸化 NF-κB 和细胞周期蛋白 D1 的表达明显升高(<0.05)。在 HCV 相关 HCC 肝脏中,核 ER 亚型的表达与核细胞周期蛋白 D1呈正相关,细胞质 ER 亚型的表达与细胞质磷酸化 IKK 呈负相关。这些发现表明,慢性 HCV 感染后 ER 亚型表达的失调可能导致 HCV 相关肝硬化向 HCV 相关 HCC 的进展。

结论

在正常肝脏中观察到 ERα表达存在性别差异。在病变肝脏中观察到的 ER 亚型表达的改变可能会影响 HCV 相关发病机制中的性别差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fec/5645614/735de39059f2/WJG-23-6802-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fec/5645614/5d7958e6d22a/WJG-23-6802-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fec/5645614/8a906f9e2a10/WJG-23-6802-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fec/5645614/f6ea4457aa80/WJG-23-6802-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fec/5645614/f75ba3746989/WJG-23-6802-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fec/5645614/735de39059f2/WJG-23-6802-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fec/5645614/5d7958e6d22a/WJG-23-6802-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fec/5645614/8a906f9e2a10/WJG-23-6802-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fec/5645614/f6ea4457aa80/WJG-23-6802-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fec/5645614/f75ba3746989/WJG-23-6802-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fec/5645614/735de39059f2/WJG-23-6802-g005.jpg

相似文献

1
Estrogen receptor expression in chronic hepatitis C and hepatocellular carcinoma pathogenesis.雌激素受体在慢性丙型肝炎和肝细胞癌发病机制中的表达。
World J Gastroenterol. 2017 Oct 7;23(37):6802-6816. doi: 10.3748/wjg.v23.i37.6802.
2
The clinical and pathogenetic significance of estrogen receptor-beta expression in chronic liver diseases and liver carcinoma.雌激素受体-β在慢性肝病和肝癌中的表达的临床及发病机制意义
Cancer. 2003 Aug 1;98(3):529-34. doi: 10.1002/cncr.11528.
3
Aberrant estrogen receptor alpha expression correlates with hepatocellular carcinoma metastasis and its mechanisms.异常雌激素受体α表达与肝细胞癌转移及其机制相关。
Hepatogastroenterology. 2014 Jan-Feb;61(129):146-50.
4
Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.肉豆蔻酰化富含丙氨酸的蛋白激酶C底物在肝细胞癌、肝硬化、慢性肝炎及正常肝脏中表达的比较研究
Int J Oncol. 2005 Mar;26(3):661-71.
5
Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.甲萘醌四烯甲萘醌,一种维生素K2类似物,通过抑制核因子κB激活来抑制细胞周期蛋白D1的表达,从而抑制肝癌细胞的生长。
Clin Cancer Res. 2007 Apr 1;13(7):2236-45. doi: 10.1158/1078-0432.CCR-06-2308.
6
Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation.雌激素受体α和β在调节尿路上皮细胞增殖中的作用。
Endocr Relat Cancer. 2008 Mar;15(1):351-64. doi: 10.1677/erc.1.01255.
7
Constitutive activation of nuclear factor kappaB in hepatocellular carcinoma.核因子κB在肝细胞癌中的组成性激活
Cancer. 2000 Dec 1;89(11):2274-81.
8
Immunohistochemistry panel segregates molecular types of hepatocellular carcinoma in Brazilian autopsy cases.免疫组织化学检测区分巴西尸检病例中肝细胞癌的分子类型。
World J Gastroenterol. 2016 Jul 21;22(27):6246-56. doi: 10.3748/wjg.v22.i27.6246.
9
Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.慢性丙型肝炎病毒感染相关的肝纤维化、肝硬化或肝细胞癌患者肝脏及血清中p53蛋白的表达
Clin Biochem. 2009 Apr;42(6):455-61. doi: 10.1016/j.clinbiochem.2008.11.004. Epub 2008 Nov 27.
10
Interferon regulatory factor 5 (IRF5) suppresses hepatitis C virus (HCV) replication and HCV-associated hepatocellular carcinoma.干扰素调节因子 5(IRF5)抑制丙型肝炎病毒(HCV)复制和 HCV 相关的肝细胞癌。
J Biol Chem. 2017 Dec 29;292(52):21676-21689. doi: 10.1074/jbc.M117.792721. Epub 2017 Oct 27.

引用本文的文献

1
Sex based relative expression of estrogen receptors and tumor necrosis factor-alpha in liver affects hepatitis C virus viral pathogenesis.肝脏中雌激素受体和肿瘤坏死因子-α基于性别的相对表达影响丙型肝炎病毒的发病机制。
World J Gastroenterol. 2025 Aug 28;31(32):104277. doi: 10.3748/wjg.v31.i32.104277.
2
To reveal the key mechanism of Citri Reticulatae Pericarpium-Reynoutria japonica Houtt in the treatment of liver cancer and its correlation with lipid metabolism: synergetic effect with network pharmacology, molecular docking and bioinformatics.揭示陈皮-虎杖治疗肝癌的关键机制及其与脂质代谢的相关性:基于网络药理学、分子对接和生物信息学的协同效应。
Discov Oncol. 2025 Jun 16;16(1):1124. doi: 10.1007/s12672-025-02708-8.
3

本文引用的文献

1
Desirable Characteristics of Hepatitis C Treatment Regimens: A Review of What We Have and What We Need.理想的丙型肝炎治疗方案的特征:对已有和所需方案的综述。
Infect Dis Ther. 2016 Sep;5(3):299-312. doi: 10.1007/s40121-016-0118-x. Epub 2016 Jul 6.
2
Estrogen receptor beta reduces colon cancer metastasis through a novel miR-205 - PROX1 mechanism.雌激素受体β通过一种新的miR - 205 - PROX1机制减少结肠癌转移。
Oncotarget. 2016 Jul 5;7(27):42159-42171. doi: 10.18632/oncotarget.9895.
3
Estrogen receptors in gastric cancer: Advances and perspectives.
Estrogen and viral infection.
雌激素与病毒感染。
Front Immunol. 2025 May 16;16:1556728. doi: 10.3389/fimmu.2025.1556728. eCollection 2025.
4
Novel role of general transcript factor IIH subunit 2 (GTF2H2) in the development and sex disparity of hepatocellular carcinoma.通用转录因子IIH亚基2(GTF2H2)在肝细胞癌发生发展及性别差异中的新作用
Oncogene. 2025 May;44(19):1323-1335. doi: 10.1038/s41388-025-03301-7. Epub 2025 Feb 19.
5
Unveiling the effect of estrogen receptors in alcoholic liver disease: A novel outlook.揭示雌激素受体在酒精性肝病中的作用:一种新观点。
Liver Res. 2023 Oct 29;7(4):333-341. doi: 10.1016/j.livres.2023.10.002. eCollection 2023 Dec.
6
Transcription factors and hormone receptors: Sex‑specific targets for cancer therapy (Review).转录因子与激素受体:癌症治疗的性别特异性靶点(综述)
Oncol Lett. 2024 Dec 6;29(2):93. doi: 10.3892/ol.2024.14839. eCollection 2025 Feb.
7
Like a Rolling Stone? A Review on Spontaneous Clearance of Hepatitis C Virus Infection.《像滚石一样?关于丙型肝炎病毒感染自发清除的综述》。
Viruses. 2024 Aug 30;16(9):1386. doi: 10.3390/v16091386.
8
Nomogram built based on machine learning to predict recurrence in early-stage hepatocellular carcinoma patients treated with ablation.基于机器学习构建的列线图,用于预测接受消融治疗的早期肝细胞癌患者的复发情况。
Front Oncol. 2024 May 10;14:1395329. doi: 10.3389/fonc.2024.1395329. eCollection 2024.
9
Novel hybrid motifs of 4-nitroimidazole-piperazinyl tagged 1,2,3-triazoles: Synthesis, crystal structure, anticancer evaluations, and molecular docking study.4-硝基咪唑-哌嗪基标记的1,2,3-三唑新型杂化基序:合成、晶体结构、抗癌评估及分子对接研究
Heliyon. 2023 Aug 24;9(9):e19327. doi: 10.1016/j.heliyon.2023.e19327. eCollection 2023 Sep.
10
Translocation of Methionine Adenosyl Transferase MAT2A and Its Prognostic Relevance for Liver Hepatocellular Carcinoma.甲硫氨酸腺苷转移酶 MAT2A 的易位及其对肝癌的预后意义。
Int J Mol Sci. 2023 May 22;24(10):9103. doi: 10.3390/ijms24109103.
胃癌中的雌激素受体:进展与展望。
World J Gastroenterol. 2016 Feb 28;22(8):2475-82. doi: 10.3748/wjg.v22.i8.2475.
4
Liver transplantation for viral hepatitis in 2015.2015年病毒性肝炎的肝移植
World J Gastroenterol. 2016 Jan 28;22(4):1570-81. doi: 10.3748/wjg.v22.i4.1570.
5
Liver pathology of hepatitis C, beyond grading and staging of the disease.丙型肝炎的肝脏病理学,超越疾病的分级和分期。
World J Gastroenterol. 2016 Jan 28;22(4):1357-66. doi: 10.3748/wjg.v22.i4.1357.
6
Influence of female sex on hepatitis C virus infection progression and treatment outcomes.女性性别对丙型肝炎病毒感染进展及治疗结果的影响。
Eur J Gastroenterol Hepatol. 2016 Apr;28(4):405-11. doi: 10.1097/MEG.0000000000000567.
7
ERα36--Another piece of the estrogen puzzle.ERα36--雌激素之谜的又一块拼板。
Eur J Cell Biol. 2015 Dec;94(12):611-25. doi: 10.1016/j.ejcb.2015.10.001. Epub 2015 Oct 21.
8
Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability.肝细胞癌的全球流行病学:着重于人口统计学和区域变异性。
Clin Liver Dis. 2015 May;19(2):223-38. doi: 10.1016/j.cld.2015.01.001. Epub 2015 Feb 26.
9
Interplay of estrogen receptors and FOXA factors in the liver cancer.雌激素受体与FOXA因子在肝癌中的相互作用。
Mol Cell Endocrinol. 2015 Dec 15;418 Pt 3(0 3):334-9. doi: 10.1016/j.mce.2015.01.043. Epub 2015 Feb 4.
10
Estrogen receptors in prostate development and cancer.雌激素受体在前列腺发育和癌症中的作用
Am J Clin Exp Urol. 2014 Jul 12;2(2):161-8. eCollection 2014.